Abstract
17(R),18(S)-Epoxyeicosatetraenoic acid [17(R),18(S)-EETeTr], a cytochrome P450 epoxygenase metabolite of eicosapentaenoic acid (EPA), exerts negative chronotropic effects and protects neonatal rat cardiomyocytes against Ca 2+-overload with EC50 ≈ 1-2 nM. Structure-activity studies revealed that a cis-Δ11,12- or Δ14,15- olefin and a 17(R),18(S)-epoxide are minimal structural elements for antiarrhythmic activity whereas antagonist activity was often associated with the combination of a Δ14,15-olefin and a 17(S),18(R)-epoxide. Compared with natural material, the agonist and antagonist analogues are chemically and metabolically more robust and several show promise as templates for future development of clinical candidates.
Original language | English (US) |
---|---|
Pages (from-to) | 4109-4118 |
Number of pages | 10 |
Journal | Journal of Medicinal Chemistry |
Volume | 54 |
Issue number | 12 |
DOIs | |
State | Published - Jun 23 2011 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery